Last reviewed · How we verify
NCT05423899
Humanoid Robot vs Treatment as Usual for Loneliness
NA trial testing Grace Robot in Loneliness. Withdrawn.
1 March 2023
Quick facts
| Lead sponsor | Lady Davis Institute |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Start date | 1 September 2022 |
| Primary completion | 1 March 2023 |
| Estimated completion | 30 March 2023 |
Drugs / interventions tested
- Grace Robot
- Treatment as Usual
Conditions studied
- Loneliness — all drugs for Loneliness →
- Depression — all drugs for Depression →
- Stress — all drugs for Stress →
- Anxiety — all drugs for Anxiety →
Sponsor
Lady Davis Institute
Who can join
60 and older, any sex, with Loneliness or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators are aiming to compare the effects of a humanoid robot intervention to treatment as usual, on loneliness and mental health outcomes in older adults living in long-term care, through an assessor-blinded randomized controlled trial.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Humanoid robot intervention vs. treatment as usual for loneliness in long-term care homes: Study protocol for a pilot randomized controlled trial.
Lavin P, Lesage M, Monroe E, Kanevsky M, et al · · 2022 · cited 2× · PMID 36339874 · DOI 10.3389/fpsyt.2022.1003881
Verify or expand the search:
- PubMed search for NCT05423899
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Loneliness
Currently open trials in the same condition.
- NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
- NCT07443813 — An Innovative App-based Intervention to Promote Social Connectedness and Well-being in Older Adults · NA · active not recruiting
- NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting
- NCT07107906 — Evaluating and Implementing The CONNECT Program - a Group-Based Telehealth Intervention to Reduce Social Isolation, Lone · NA · recruiting
- NCT06919094 — A Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults · NA · recruiting
Other Lady Davis Institute trials
Trials by the same sponsor.
- NCT06373263 — Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1 · NA · not yet recruiting
- NCT06772896 — Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic Sclerosis · NA · completed
- NCT06588101 — Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU · NA · recruiting
- NCT05366088 — RCT of MBCT vs HEP for Late-Life Depression · NA · terminated
- NCT06189118 — Online MBCT vs HEP for Depressive Symptoms in Older Adults: RCT · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05423899 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lady Davis Institute
- Last refreshed: 16 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05423899.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing